Tempus
Tempus es una empresa tecnológica que promueve la medicina de precisión a través de conocimientos basados en datos. La plataforma de la empresa utiliza inteligencia artificial y aprendizaje automático para analizar datos clínicos y moleculares, ayudando a investigadores y médicos a tomar decisiones más informadas en la atención al paciente. El trabajo pionero de Tempus en el análisis de datos y la genómica está reconfigurando el enfoque del diagnóstico y el tratamiento de las enfermedades, especialmente el cáncer.
Gráfico NewsHeat
- Semana
- Mes
- Año
- Noticias de prensa
- Noticias corporativas
Los datos del gráfico anterior se basan en datos derivados de nuestro modelo de cálculo XP patentado y pueden modificarse, ajustarse y actualizarse sin previo aviso.
Valoración de empresas
- Valoración
- Precio de las acciones
- Financiación acumulada
Los datos de los cuadros y gráficos se basan en datos de fuentes públicas y, aunque hacemos todo lo posible por recopilarlos, es posible que no coincidan con los datos reales del emisor.
*** - Para ver los datos, conéctese a su cuenta o cree una nueva.
Noticias relacionadas con Tempus167
Tempus Announces Real World Data Collaboration with BioNTech - Tempus
The strategic collaboration will leverage Tempus’ large multimodal datasets to enhance BioNTech’s next-generation oncology pipeline Tempus AI, Inc. (NASDAQ: TEM, “Tempus”), a technology company leading the adoption of AI to advance precision medicine and ...
Tempushttps://www.tempus.com/news/tempus-announces-real-world-data-collaboration-with-biontech/Tempus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference - Tempus
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4th, held in New York, N...
Tempushttps://www.tempus.com/news/tempus-to-present-at-the-morgan-stanley-22nd-annual-global-healthcare-conference/World Clinical Biomarkers & CDx Summit 2024 - Tempus
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 14th annual World CB & CDx Summit and present how Tempus can support strategic CDx development through to comme...
Tempushttps://www.tempus.com/events/world-cb-cdx-2024/Tempus Evening Reception: NSGC 2024 - Tempus
Join Tempus at Sidecar Patio & Oyster Bar to explore our cutting-edge advancements in precision medicine. Mingle with industry peers while enjoying local food and refreshments in the picturesque New Orleans courtyard....
Tempushttps://www.tempus.com/events/tempus-evening-reception-nsgc-2024/Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting with HER2 - Tempus
Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced the launch of a new program specifically geared towards using algorithms to surface patients who are more likely to test positive for actionable bio...
Tempushttps://www.tempus.com/news/tempus-next-launches-new-algorithm-to-close-care-gaps-in-guideline-directed-ihc-testing-starting-with-her2/